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PhysalisminimaL.isreputedforhavinganticancerproperty.Inthisstudy,thechloroformextractofthisplantexhibitedremarkable
cytotoxic activities on NCI-H23 (human lung adenocarcinoma) cell line at dose- and time-dependent manners (after 24, 48 and
72h of incubation). Analysis of cell-death mechanism demonstrated that the extract exerted apoptotic programed cell death
in NCI-H23 cells with typical DNA fragmentation, which is a biochemical hallmark of apoptosis. Morphological observation
using transmission electron microscope (TEM) also displayed apoptotic characteristics in the treated cells, including clumping
and margination of chromatins, followed by convolution of the nuclear and budding of the cells to produce membrane-bound
apoptotic bodies. Diﬀerent stages of apoptotic programed cell death as well as phosphatidylserine externalization were conﬁrmed
using annexin V and propidium iodide staining. Furthermore, acute exposure to the extract produced a signiﬁcant regulation of
c-myc, caspase-3 and p53mRNA expression in this cell line. Due to its apoptotic eﬀect on NCI-H23 cells, it is strongly suggested
that the extract could be further developed as an anticancer drug.
1.Introduction
Lung cancer remains a major global health problem,
accounting for more than a million annual deaths worldwide
[1]. It is twice the death rate of the second-most prevalent
cancer, that is, prostate cancer in men [2]. The incidence of
lung cancer can be correlated with the age of both males and
females and there is still lack of eﬀective drugs to treat this
disease [3].
Herbal formulation consisting of single and multiple of
h e r b si sc o m m o n l yp r e s c r i b e da sa na l t e r n a t i v ew a yt ot r e a t
cancer. An anticancer plant that was selected for this study
is Physalis minima L. The decoction of the whole plant is
taken orally to treat cancer and the leaves are used as a
poulticeforulcer[4,5].Thisherbiscommonlyknownasthe
bladder cherry (Leletup-direct translation from Malay) and
belongs to the Solanaceae family [5]. Its reputed eﬃcacy in
treating cancer has been validated (in vitro) against CORL23
lung and MCF7 breast cancer cell lines, but the mechanisms
underlying the anticancer activity still remain unknown.
Two active anticancer compounds have been isolated from
its methanol extract of stem and leaf and were identiﬁed
as physalin B and physalin F [6]. However, these two
compounds were found to exhibit non-selective cytoxicity
against all tested human cell lines including non-cancerous
cell with physalin F consistently more active [6, 7].
Recently, intensive studies have been conducted to exam-
ine the mechanism responsible for the anticancer eﬀects
of plant-based drugs. Apoptosis is a speciﬁc mode of cell
death that can only target cancer cell with little or no
damage to non-cancerous cells [8]. It helps in reducing
the incidence of side eﬀect in patients [9]. Information on
the apoptotic eﬀect elicited by the extracts and bioactive
compounds of Physalis sp. are still limited to a few ﬁndings,
such as the cell death signaling eﬀects of physalins B and
F on PANC-1 pancreatic cancer cells. They were reported2 Evidence-Based Complementary and Alternative Medicine
as potent inhibitors for the aberrant hedgehog (Hh)/GLI
signaling pathway (that causes formation and progression of
various cancers) by inhibiting GL2-mediated transcriptional
activation, decreasing hedgehog-related component expres-
sion and reducing the level of anti-apoptotic Bcl-2 gene
expression [10]. Moreover, apoptotic induction in human
lung cancer H661 cells by the supercritical carbon dioxide
extract of Physalis peruviana was associated with cell cycle
arrest at the S phase, mediated through the p53-dependent
pathway and modiﬁcation of pro-apoptotic protein (Bax)
and inhibitor of apoptosis protein (IAP) expression [11].
In addition, the ethanol extract of P. peruviana was found
to induce apoptosis on human liver cancer Hep G2 cells
through CD95/CD95L system and the mitochondrial signal-
ing transduction pathway [12]. Furthermore, the methanol
extract of Physalis angulata induced apoptosis and arrested
human breast cancer MAD-MB 231 cells at G2/M phase
[13] and induced apoptosis in human oral cancer HSC-3
cellsthroughoxidativestress-dependentinductionofprotein
expression such as heme oxygenase-1 and Cu/Zn superoxide
dismutase [14].
Based on our previous comparative cytotoxicity studies
of the extracts and fractions (obtained from the chloroform
extract) of Physalis minima, it has been established that the
anti-proliferativeactivityofthechloroformextractinhuman
lung adenocarcinoma NCI-H23 cells was relatively better
than other extracts and its fractions [15]. Therefore, it was
selected for this study with aims (i) to evaluate the eﬀect
of the extract to NCI-H23 cells proliferation in diﬀerent
incubation periods and (ii) to determine the cell death
mechanism elicited by the extract via morphological and
molecular investigations.
2. Methods
2.1. Chemicals. The DeadEnd Colometric Apoptosis Detec-
tion System was purchased from Promega, USA. The
Annexin-V-FLOUS kit was purchased from Roche Diagnos-
tics, Germany. The methylene blue assay, dimethyl sulfoxide
(DMSO) and propidium iodide were obtained from Sigma
Aldrich, USA. All culture media and additives were from
Hyclone, USA. All other chemicals were reagents of molec-
ular grade, as appropriate.
2.2. Preparation of Crude Extracts. The P. minima plant
was collected from Arau-Perlis, Malaysia. The plant was
identiﬁed and veriﬁed by Mr V. Shunmugam of Universiti
Sains Malaysia. The voucher specimen (no. 11001) was
preserved and deposited in the herbarium of School of
Biological Sciences, Universiti Sains Malaysia.
The whole plant materials were washed, dried and
chopped ﬁnely using a grinder. The dried material was then
transferred into the Soxhlet extractor. The dried plant mate-
rial was exhaustively extracted with chloroform by Soxhlet
extraction. The extracts were ﬁltered and concentrated using
rotaryevaporator,andthenevaporatedtodryness.Thedried
extracts were then weighed using microbalances (Sartorius,
Germany) and reconstituted with 99.9% (v/v) DMSO to
prepare astock solution ata concentrationof 10mg/mL. The
stock solution was serially diluted to eight diﬀerent working
concentrations. As for the positive control, the stock solution
of vincristine sulfate (a commercial drug) at a concentration
of 1mg/mL was prepared using DMSO and diluted serially
to 24 diﬀerent concentrations.
2.3. Cell Line and Culture Medium. NCI-H23 (human lung
adenocarcinoma) cell line was obtained from American
Type Cell Culture (ATCC), USA, and cultured in RPMI
1640, supplemented with 2mM l-glutamine, 10% (v/v)
fetal calf serum (FCS), 100U/mL penicillin and 100μg/mL
streptomycin, as recommended by ATCC.
2.4. In Vitro Cytotoxicity Assay. Nearly conﬂuent cultures
of cells were harvested with 0.05% (w/v) Trypsin-EDTA.
Cells were then centrifuged and pellet resuspended with a
complete medium with 10% (v/v) FCS. Then, 100μLo f
cells were plated into each well of 96-well plate at a density
of ∼6000cells/well. Cell viability was routinely determined
using the trypan blue exclusion test to ensure it was always
in excess of 95%. The cells were then allowed to attach
and incubate at 37
◦Ci naC O 2 incubator for a further
24–48h. After the cells reached 80–90% conﬂuence, the
medium wasremovedand replacedwithmedium containing
only 0.5% (v/v) FCS and the cells were incubated for
further 4h. The reason for this was for the cells to achieve
quiescent. Subsequently, the cells were treated with diﬀerent
concentrations of extracts. Controlled cells were cultured in
a0.5%(v/v)FCS-containingmediumalone.Ofserialdiluted
extracts, 1μL was added into each well. After treatment, the
plateswereincubated for72h.Vincristine sulfatewasused as
a positive control.
Cell survival was determined by the procedure using
methylene blue staining as described by Yamazaki et al.
[16]a n dL ia n dH w a n g[ 17]. After 72h of incubation with
plant extracts, the surviving cells were ﬁxed with 2.5%
(v/v) glutaraldehyde for 15min and were then washed with
a 0.15M sodium chloride (NaCl) solution to remove the
dead cells. The ﬁxer cells subsequently were stained with
100μL of 0.05% (w/v) methylene blue solution for 15min.
After washing oﬀ the excess dye with NaCl, dye elution
was carried out using 200μL of 0.33M hydrochloric acid
(HCl). Absorbance was read at 650nm using Vmax Kinetic
Microplate Reader (Molecular Devices, USA). The number
of surviving cells was determined from the absorbance value.
2.5. Detection of DNA Fragmentation. Nuclear DNA frag-
mentation was detected using DeadEnd Colometric Apop-
tosis Detection System (Promega, USA). Brieﬂy, cell suspen-
sions were subcultured on Labtek Chamber Slides, and then
incubated for 24–48h. When the cells achieved conﬂuency
between 80% and 90%, the medium was replaced with a
medium containing only 0.5% (v/v) FCS. The cells were
then incubated at 37
◦C for 4h and treated with the P.
minima chloroform extract at a concentration of EC50 at
72h (2.80μg/mL). Negative control cells were treated with
the same concentration of DMSO. Positive control cellsEvidence-Based Complementary and Alternative Medicine 3
were treated with DNase I (1U/mL) and vincristine sulfate
at a concentration of EC50 at 72h (0.0015μg/mL). In all
cases, the ﬁnal concentration of DMSO in each control slide
did not exceed 1% (v/v). The slides were then incubated
for 24h. After treatment, the cells were rinsed twice with
a phosphate-buﬀered saline (PBS), and then processed
according to the DeadEnd Colometric Apoptosis Detection
System protocol as described by the manufacturer (Promega,
USA). Subsequently, the slides were observed using the
light microscope (Olympus BH2 light microscope) and the
imagestakenusingtheAnalySISDocuSoftImagingSoftware,
Germany.
2.6. Detection of Plasma Membrane Integrity. In order to
detect the loss of plasma membrane of necrotic cells, the
NCI-H23 cells were cultured on 6-well plates, and then
incubated for 24–48h. When the cells reached between 80%
and 90% conﬂuency, the medium was replaced with a fresh
medium containing only 0.5% (v/v) FCS. The cells were
then incubated for a further 4h and treated with the P.
minima chloroform extract at a concentration of EC50 at
72h (2.80μg/mL). Negative control cells were treated with
the same concentration of DMSO. The cells were rinsed with
PBSandstainedusingthetrypanblueexclusionassayafter24
and 72h incubation period. Subsequently, the samples were
viewed using an inverted phase contrast light microscope.
2.7. Ultrastructural Analysis. NCI-H23 cells were incubated
with the P. minima c h l o r o f o r me x t r a c ta tac o n c e n t r a t i o n
of EC50 at 72h (2.80μg/mL) for 24h. Negative control cells
were treated with the similar concentration of DMSO. After
incubation, the cells were trypsinized, centrifuged and then
resuspended twice with PBS. The cells were then rinsed,
pelleted and then resuspended in the McDowell-Trump
ﬁxative solution [containing 4% (v/v) formaldehyde and
1% (v/v) glutaraldehyde in a 0.1M phosphate buﬀer, pH
7.3] at 4◦C for 24h. The cells were pelleted and rinsed
in a 0.1M phosphate buﬀer for 10min and repeated three
times. Post-ﬁxed was carried out with 1% (w/v) osmium
tetroxide prepared in a 0.1M phosphate buﬀer for 1-2h at
room temperature. The cells were then dehydrated with 50%
(v/v) ethanol for 15min, followed by 75% (v/v) ethanol for
15min, 95% (v/v) ethanol for 15min and repeated, 100%
(v/v) ethanol for 30min and repeated and, lastly, 100% (v/v)
acetone for 10min and repeated. Inﬁltration was conducted
using the mixture of acetone:Spurr’s resin mix (1:1) in a
rotator for another 2-3 days with a daily change of Spurr’s
mix of each sample specimen. Subsequently, the cells were
embedded and cured at 60
◦C for 12–48h.
Sectioning was preceded by the analysis of a semi-thin
section (1μm), stained at 40
◦C with 1% (w/v) toluidine
blue. This was then followed by sectioning of thin sections
(<1μm), collected using copper grids. Reichart Supernova
Ultra Microtome was used to produce the sections. The
thin sections were stained with uranyl acetate for 15min
by complete immersion, in a covered Petri-dish lined with
dental wax. Lastly, the sections were stained with lead citrate
using the same procedures. The samples were examined
and observed under a Philips CM 12 transmission electron
microscope (TEM).
2.8. Detection of Phosphatidylserine Externalization. NCI-
H23 cells were incubated with the P. minima chloroform
extract at a concentration of EC50 at 72h (2.80μg/mL)
for 24h. Negative control cells were treated with the
similar concentration of DMSO. After treatment, the cell
in the chamber slides were washed with PBS twice and
subsequently processed according to the Annexin-V-FLUOS
(Roche Diagnostics, Germany) (combination of annexin
V and propidium iodide) protocol as described by the
manufacturer’s instruction. Subsequently, the slides were
immediately analyzed using a ﬂuorescence microscope with
an excitation wavelength in the range of 450–500nm and
detection in the range of 515–565nm (green). Photos were
taken using the Olympus BH2-RFCA Fluorescence Micro-
scope with Olympus camera attachment. Green ﬂuorescence
was observed in annexin V positive cells and red ﬂuorescence
in cells which uptake the propidium iodide dye.
2.9. Determination of Apoptotic-Related Genes Expression.
In order to investigate the mRNA expression levels of c-
myc, caspase-3 and p53, which are responsible to trigger
apoptosis mechanism, semi-quantitative reverse transcrip-
tion polymerase chain reaction (RT-PCR) was carried out.
NCI-H23 cells were cultured in T25 ﬂasks and starved
with a medium containing only 0.5% (v/v) FCS for 4h.
The cells were then treated with the P. minima chloroform
extract at a concentration of EC50 at 72h (2.80μg/mL) for
the period of 24h. After treatment, the total cellular RNA
was isolated using the Tri-Reagent LS (Molecular Research
Center, USA) according to the manufacturer’s instructions.
Of the isolated total cellular RNA sample, 1μgw a st r e a t e d
with DNase I, followed by reverse transcribed into cDNA
and subjected to PCR ampliﬁcation. The optimized PCR
ampliﬁcation program comprised an initial denaturation
step at 94
◦C for 2min, followed by denaturation at 94
◦C
for 45s, annealing at 56
◦C for 1min, extension at 72
◦C
for 2min and ﬁnal extension step at 72
◦C for 10min.
The PCR optimization process including the optimal cDNA
concentration and the number of ampliﬁcation cycles used
to amplify c-myc, caspase-3, p53 and β-actin genes was in
the exponential phase of PCR ampliﬁcation (i.e. provide a
linear relationship between the amount of ampliﬁcation and
the concentration of the original cDNA temples) (data not
shown), indicating that the conditions were optimized for
semi-quantitative studies [14, 15]. The sequences of primers
for analysis were synthesized based on the human mRNA
encoding the respective genes. The ampliﬁcation products
were separated on 1.2% (w/v) agarose gel and stained with
ethidium bromide. Gene expressions signaling at each point
of time were quantiﬁed using GeneTools analysis software on
GENE GENIUS gel documentation system (Syngene, UK).
The signals of c-myc, p53 and caspase-3 were normalized
from β-actin and the ratio in unstimulated samples was
assigned as 1. The housekeeping gene β-actin was used as an
internal standard control.4 Evidence-Based Complementary and Alternative Medicine
2.10. Calculation and Statistics. Cytotoxicity experiments
were performed in six replicates and results were expressed
as percentage growth inhibition of control. EC50 values
for growth inhibition was derived from a nonlinear model
(curvﬁt) based on the sigmoidal dose response curve (vari-
able) and computed using GraphPadPrism, USA. Data are
given as mean ± SEM. The criterion of cytotoxic or non-
cytotoxicwasadaptedfromtheguidelinessetbytheNational
Cancer Institute (NCI) which indicated that plant extracts
with EC50 ≤ 20μg/mL were considered to be cytotoxic and
non-cytotoxic if otherwise [18].
DNA fragmentation experiments were conducted in
triplicate. The cells from ﬁve random microscopic ﬁelds were
countedtogetthepercentageofTUNELpositive cells(apop-
totic index, AI% = number of apoptotic nuclei/number of
nuclei scored ×100%) using 200x magniﬁcations and the
mean percentage ± SEM was calculated. The signiﬁcant
diﬀerences between the mean percentage of positive stained
nuclei of control cells and treated cells were determined
using one-way ANOVA, computed using GraphPadPrism
(Graphpad, USA).
The signiﬁcant diﬀerences in the ratio to β-actin
(between each time point and control) were determined
using one-way ANOVA and Dunnett’s Multiple Comparison
Test for post-comparison tests, computed using GraphPad-
Prism software (GraphPad, USA). Diﬀerences were consid-
ered to be signiﬁcant if P<. 05.
3. Results
3.1. Cytotoxic Eﬀect of the Chloroform Extract of P. minima
on NCI-H23 Cells. Dose-dependent inhibitions in NCI-H23
cells were observed when the cells were treated with this
extract at all incubation intervals (Figure 1). Interestingly,
the chloroform extract produced >75% of growth inhibition
in NCI-H23 cells, which appeared to be relatively unchanged
at higher concentrations (25–100μg/mL) for all time points
(Figure 1). After 24h of treatment, only at a concentration
of 6.25μg/mL and above, the chloroform extract signiﬁ-
cantly inhibited the growth of NCI-H23 cells (P<. 05).
Meanwhile, after 48 and 72h of incubation, at most tested
concentrations (100–1.563μg/mL), the extract exhibited
signiﬁcant inhibitory eﬀects (P<. 05). The inhibitory
activities increased and the EC50 values decreased as the
incubation periods were increased from 24h (5.28μg/mL) to
48h (3.55μg/mL) and 72h (2.80μg/mL). However, the EC50
forvincristinesulfate(0.0015μg/mL)wasverymuchloweras
compared to the EC50 deduced from the chloroform extract
at 72h incubation period (data not shown).
3.2. Eﬀect of P. minima Chloroform Extract on Cell Death of
NCI-H23 Cells. I no r d e rt oi n v e s t i g a t ew h e t h e ra p o p t o s i s
may play an important role in mediating the cell death
of NCl-H23 cells elicited by the chloroform extract of P.
minima, the fragmented genomic DNA was detected using
a modiﬁed TUNEL assay. As shown in Figures 2(b), 2(c) and
2(d),theextract-treatedNCl-H23cellsproduceddarkbrown
stained nuclei with similar observation found in the positive
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Figure 1: Eﬀect of P. minima chloroform extract on proliferation
of NCI-H23 cells at 24, 48 and 72h. Each value represented mean ±
SEM of six replicates (n = 6); ∗P<. 05.
control cells treated with DNase I and vincristine sulfate.
The nuclei were speciﬁcally stained and evenly distributed.
Most of the positive stained nuclei were rounded or oblong
in shape. But almost all nuclei of untreated negative control
cells were not stained with this assay (Figure 2(a)). The
mean percentage of apoptotic index for the extract-treated
NCl-H23 cells was 49.89% and signiﬁcantly diﬀerent as
compared to the negative control (DMSO) (1.39%) (P<
.001) (Figure 2(e). Comparatively, the percentage was lower
than that in positive controls (68.41% and 56.40% for DNase
I and vincristine sulfate, resp.). This result strongly indicated
that apoptosis was one of the possible type of cell death in
NCl-H23 cells after 24h exposure to the chloroform extract.
The trypan blue exclusion assay showed that only a few
NCl-H23 cells were positively stained after treated with the
extract for 24 and 72h. The results strongly suggested that
the surface of most treated cells was intact after incubation
with the extract at both time points (Figures 3(a) and 3(b).
Therefore, the mode of cell death elicited by the chloroform
extract of P. minima in NCI-H23 cells was unlikely via
necrotic mechanism in nature.
TEM analysis exhibited diﬀerent morphological alter-
ations in NCI-H23 cells after treatment with the chloroform
extract of P. minima for 24h. Characteristics of apoptotic
cell death were observed in the majority of treated NCI-H23
cells.Therewasclumpingofthenuclearchromatinintomore
denselypackedmaterialthatbecomesmarginatedagainstthe
nuclear membrane (Figure 4(a)). This was accompanied by
a convolution of nuclear envelope and cytoplasmic mem-
brane (Figure 4(b)). However, the cytoplasmic membrane
and cell organelles remained intact. Budding of cells was
clearly demonstrated (Figure 4(c)), where the cytoplasmic
membrane formed extensions and separated. The plasma
membrane was then sealed to produce membrane-bound
apoptotic bodies that contained cellular material of the
cells in various combinations. These ultrastructural analysisEvidence-Based Complementary and Alternative Medicine 5
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Figure 2: The eﬀect of (a) DMSO l% (v/v), (b) Physalis minima chloroform extract (2.80μg/mL, EC50 a 72h), (c) DNase I (1U/mL) and (d)
vincrstinesulphate(0.0015μg/mL,EC50 at72h)orNCI-H2:cellsfor24handsubjectedtoDeadendColometricApoptosisDetectionSystem
(Promega, USA) Apoptotic cells with stained nuclei were rnarked by arrows. (e) Comparison of the mean percentage of apoptotic index
between DNase 1-, vincristine sulphate- and P. minima chloroform extract-treated cells to untreated cells (DMSO) at 24 hours treatment
in diﬀerent cell lines. Each value represented mean ± SEM from three independent experiments. ∗P<. 001 (as compared with negative
control).
(a) (b)
Figure 3: Trypan blue staining of NCI-H23 cells treated with P. minima chloroform extract (2.80μg/mL, EC50 at 72h) post 24 (a) and 72h
(b) (Original magniﬁcation ×200). Necrotic cells were marked by arrow.
results clearly indicated that apoptosis appeared to be
the dominant mechanism of cell death exerted by the
chloroform extract of P. minima in NCI-H23 cells. As for
negative control, the DMSO-treated cells did not show these
morphological characteristics (data not shown).
The existence of apoptotic programed cell death elicited
by chloroform extract of P. minima in NCI-H23 cells
was conﬁrmed using Annexin-V-FLUOS assay (Roche, Ger-
many). The early phase of apoptosis or programed cell death
was evident in most of the cells as shown in Figures 5(a) and
5(b), with weakly scattered ﬂuorescent annexin V (green).
Only a few homogeneous and high intensity annexin V
staining pattern was observed, indicating a later phase of
apoptosis or programed cell death (Figure 5(a)). Meanwhile,
some cells were positively stained with both annexin V and
propidium iodide, which referred to as late stage apoptosis
(secondarynecrosis)andprogramedcelldeath(Figure 5(b)).
However, the DMSO-treated cells (negative control) did not
exhibit these staining patterns (data not shown). Thus, the
diﬀerent stages of apoptosis or programed cell death were6 Evidence-Based Complementary and Alternative Medicine
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Figure 4: Morphological features of apoptosis in NCI-H23 cells after treated with Physalis minima chloroform extract (2.80μg/mL, EC50
at 72h) for 24h. (a) Chromatin clumping (Cclp), chromatin margination (Cmrg), (b) convolution of nuclear membrane (MNcov) and
cytoplasmic outlines (MCcov), (c) budding of cell (MCbud) and led to the formation of apoptotic bodies (AB), were observed (shown by
arrows).
20microns
(a)
20microns
(b)
Figure 5: The eﬀect of P. minima chloroform extract (2.80μg/mL at 72h) on NCI-H23 cells for 24h and subjected to Annex-V-FLUOS kit
(Roche, Germany). A weakly scattered annex in V staining pattern of cell surface was evident in most of the cells (thin arrows). Only a few
of homogenous-high intensity of annex in V ﬂuorescence cells (thick arrow) and both annex in V-propidium iodide stained cells (green and
red ﬂuorescence) (dotted arrows) were also observed.
evident in NCI-H23 cells treated with the chloroform extract
of P. minima.
3.3. Eﬀect of P. minima Chloroform Extract on Apoptosis-
Related Genes Expression Level of NCI-H23 Cells. Semi-
quantitative RT-PCR was used in this study in order to
determine the expression levels of apoptosis-related genes
in P. minima chloroform extract-treated NCl-H23 cells. As
shown in Figures 6(a) and 6(b), the expression of c-myc at
rest (0h) was not much diﬀerent from stimulated cells at
15min and 30min and slightly increased for the next 90min
before reaching a peak at 3h (2.1-fold increase). However,
the expression of c-myc was then reduced at 6h (1.7-fold
increase) and gradually decreased to baseline levels at 18
and 24h. The mRNA expression of c-myc was statistically
signiﬁcant at 2, 3 and 6h post-stimulation as compared to
untreated cells (P<. 05) (Figure 6(b)).
As for the caspase-3 gene, the mRNA expression was
induced as early as 15min and still increased at 30min
but declined minimally for the next 30min and gradually
reaching its peak at 3h with an ∼2.4-fold increase (Figures
6(a) and 6(b)). However, the mRNA expression of caspase-3
was slightly reduced for the next 3h (2.0-fold increase) and
decreased steadily to the lowest levels at 18 and 24h time
points. When compared to control cells, the marked increase
of caspase-3mRNA expression was proven to be statistically
signiﬁcant from 30min to 12h post-stimulation (P<. 05)
(Figure 6(b)).
By contrast, the level of p53mRNA expression was very
low at rest (0h) but increased dramatically at 15min and
remained elevated for the next 75min before reaching the
highest peak at 2h (2.8-fold increase) (Figures 6(a) and
6(b)) .Th eh i ghm R N Ae x p r e s s i o no fp 5 3a p pe a r edt os u s t a i n
until the ninth hour and declined slightly at 12h and
eventually decreased to the lowest level at 24h. In addition,
the p53 expression was statistically higher than that control
cells from 15min to 18h (P<. 05) (Figure 6(b)).
Overall, NCl-H23 cells treated with the chloroform
extract of P. minima exhibited high mRNA expression
levels of c-myc, caspase-3 and p53 within 2–6h post-
stimulation. Caspase-3 and p53 genes seemed to have similar
expression patterns, whereby their expression was observedEvidence-Based Complementary and Alternative Medicine 7
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Figure 6: (a) Time course mRNA expression of β-actin, c-myc,
caspase-3 and p53 in NCI-H23 cells incubated in the absence
or presence of P. minima chloroform extract. β-actin was used
as an internal standard control for each PCR reation. (b) Semi-
quantitative analysis of the c-myc, caspase-3 and p53mRNA level
in NCI-H23 treated with P. minima chloroform extract using
densitometric scanning. Each value represented mean ± SEM (n =
3 at each point) of the ratio of RT-PCR product of the respective
genes to β-actin, assigning the ratio in unstimulated cells as 1.
∗P<. 05 versus C (control).
atearlypost-stimulation.Moreover,theinductionofp53and
caspase-3mRNA expression was slightly higher as compared
to that of c-myc gene. Thus, there was a clear indication that
thecelldeathinducedbythechloroformextractofP.minima
in NCl-H23 cells was mediated via the activation of c-myc,
caspase-3 and p53 gene expression.
4. Discussion
It has previously been shown that treatment using P. minima
extracts and compounds inhibited cell proliferation, but the
mechanism of cell death remained unclear [6]. In this study,
we found that the chloroform extract was able to inhibit cell
proliferation and induce apoptosis. These were conﬁrmed by
six independent methods, namely the methylene blue assay
for cytotoxicity evaluation, DeadEnd Colometric System
(Promega, USA) to label the apoptotic nuclei cells, trypan
blue exclusion assay to detect the loss of plasma membrane
integrity of necrotic cell, TEM analysis to describe the
ultrastructural or micro morphology characteristics of the
apoptotic cell, annexin V and propidium iodide staining
to detect the stages of apoptosis and RT-PCR analysis to
determine the mRNA expression level of apoptotic gene.
The extract was found to signiﬁcantly abrogate the
growth of NCI-H23 cells in a dose- and time-dependent
manner. Based on our chromatographic and spectroscopic
analyses, the extract was found to contain physalins B, F
and K [15]. These isolated physalins which are commonly
found in genus Physalis were reported with a cytotoxic
eﬀect against numerous human cell lines [7, 19, 20]. The
increase in activity of the chloroform extract as compared
with their fractions might be due to the synergistic eﬀect
of the various physalins in the extract. The occurrence of
apoptosis was initially detected based on the percentage of
apoptotic index of the extract-treated NCI-H23 cells that
was signiﬁcantly higher than that in untreated cells. DNA
fragmentation exhibited in TUNEL assay-labeled nuclei cells
is commonly used as a biochemical index of apoptosis
[21]. Analysis of plasma membrane permeability using the
trypan blue exclusion assay has ruled out necrosis as the
cause of cell death in extract-treated NCI-H23 cells. The
cross-sections of apoptotic cells were also observed using
TEM analysis of the extract-treated NCI-H23 cells. It was
recognized by stereotypical morphological changes such as
shrinking and deformation of cells, blebbing of cytoplasmic
membrane, clumping, condensation and margination of
nuclear chromatin, followed by breaking up of the cells
into small membrane-enclosed apoptotic bodies [22]. The
observation of apoptotic-morphological features was clearly
established in various studies involving anticancer agents
such as cisplatin and ﬂavopiridol that induced apoptosis
in C6 glioma cells [23] and A172 glioma cells, respectively
[24].
The apoptotic programed cell death elicited by the
chloroform extract was also conﬁrmed using the Annexin-
V-FLUOS assay (Roche, Germany). Annexin V is a Ca2+-
dependent phospholipid-binding protein that detects the
phosphatidylserine externalization of the plasma membrane
[25]. With ﬂuorescence microscopy observation, diﬀerent8 Evidence-Based Complementary and Alternative Medicine
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Figure 7: An Overview of apoptotic eﬀects elicited by P. minima chloroform extract on NCI-H23 cells. The apoptotic mechanism
was mediated by the activation of p53 (inducer and regulator), caspase-3 (executioner) and c-myc (enhancer dotted lines) which
were reputed as main molecular regulators in both extrinsic and intrinsic pathway. This was subsequently resulting in biochemical
and morphological alterations, including DNA fragmentation; phosphatidylserine (PS) externalization, chromatin migration, membrane
blebbing and apoptotic bodies.
annexin V staining patterns have been observed that indi-
cateddiﬀerentphasesofapoptosisintheextract-treatedcells.
The faintly annexin V-stained cells probably due to a limited
phosphatidylserine exposure during the early stage of apop-
tosis [26, 27]. The heavily stained annexin V and propidium
iodide cells indicated the later phase of the apoptotic process,
whereby the cells lost their plasma membrane integrity and
more binding sites of phosphatidylserine were detected [28].
The roles of c-myc, caspase-3 and p53 mRNA levels
in the chloroform extract-induced apoptotic pathways were
further veriﬁed based on their expression proﬁles at diﬀerent
timesoftreatment.Bothp53andcaspase-3weresigniﬁcantly
induced by the chloroform extract at the earlier phase of
treatment (15min and 30min, resp.). Their expressions were
sustained until the later stages of treatment and the results
provide strong evidences to support the roles of these genes
and their crosstalk in mediating the apoptosis-inducing
eﬀects of the extract. It has been well established that p53-
and caspase-mediated apoptosis of most cells are induced
throughtheactivationofthedeathreceptor(extrinsic)orthe
mitochondrial (intrinsic) pathway [29]. Overexpression of
p53 was reported to provoke the extrinsic apoptotic pathway
via the induction of death receptor proteins such as Fas and
TRAIL, which transmitted the apoptotic death signal from
the cell surface to intracellular signaling pathways [30, 31].
The pro-apoptotic function of p53 was also considered to
be associated with the mitochondrial pathway that generally
involves an induction of mitochondrial permeability transi-
tion and the subsequent release of apoptogenic factors such
as cytochrome c that leads to caspase-9 activation, which in
t u r nc l e a v e sa n da c t i v a t e se ﬀector caspases such as caspase-3
[32].
p53 was found to be induced 15min earlier than
caspase-3. This ﬁnding suggests that p53 activation may
be an upstream cellular event that leads to mitochondrial
membrane potential disappearance and caspase-3 may be
responsible in executing the downstream process of apop-
tosis that mainly contributed to the typical morphological
changes and DNA fragmentation in apoptotic cells [33].
The activation of caspase-3 has been reported in p53-
induced apoptosis in various systems [34, 35]. Caspase-
3-activated DNase that was induced by Fas-ligand or c-
myc was discovered to be associated with caspase-3 during
apoptosis [36]. The activated DNase was allowed to enter the
nucleus and caused oligonucleosomal DNA fragmentation
[37]. In agreement with this study, the ethanolic extract of
P. peruviana was reported to induce Hep G2 cells apoptosis
through the activation of caspase-3 while the elevation of
p53 expression and caspase-3 activation were observed in
its supercritical carbon dioxide extract-treated H661 cells
[11, 12].
Meanwhile, c-myc gene only demonstrated a transient
mRNAexpression(2.1-foldincrease)inextract-treatedNCI-
H23 cells at 3h of treatment. The transient increment of thisEvidence-Based Complementary and Alternative Medicine 9
gene might enhance the apoptotic eﬀect of p53 and caspase-
3 with marked peak expression of these genes at 2-3h of
treatment. This is supported by a ﬁnding that suggested c-
myc gene as a strong inducer of cell death via induction
of several pro-apoptotic signal transduction mechanisms
[38]. This gene has been described as a repressor to reduce
ubiquitination of p53 that leads to the accumulation of p53
andsubsequentlytriggerscaspase-3[31].c-mycwasreported
to induce apoptosis by destabilizing mitochondrial integrity
[39]. The upregulation of c-myc was essential to enhance the
pro-apoptotic proteins of Bcl-2 family and suppresses their
anti-apoptotic eﬀects [38, 39].
In conclusion, this study could oﬀer scientiﬁc basis for
the further in-depth evaluation of the chloroform extract
of P. minima. It inhibited the proliferation of NCI-H23
cells at dose- and time-dependent manner via an apoptotic
p r o g r a m e dc e l ld e a t h .T h ei n d u c t i o no fa p o p t o t i cc e l ld e a t h
was suggested to be mediated via p53-, caspase-3- and
c-myc-dependent cell apoptotic pathways. Based on the
results obtained in this study, we constructed a mode of
action as depicted in Figure 7. The model proposes that
the chloroform extract induced the expression of p53 that
resulting in the release of apoptogenic factors that would
facilitate the cell apoptosis through the activation of caspase
cascade.
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